Peptides for activation and inhibition of δPKC
View Patent ↗Peptides able to inhibit or activate the translocation or function of δPKC are identified. Administration of the peptides for protection or enhancement of cell damage due to ischemia is described. Therapeutic methods to reduce damage to cells or to enhance damage to cells due to ischemia are also described, as well as methods for screening test compounds for δPKC-selective agonists and antagonists.
1. A composition comprising a synthetic peptide consisting of δV1-2 (SEQ ID NO:5) linked to a moiety effective to facilitate transport across a cell membrane, wherein the synthetic peptide is at least 95% of the composition.
2. The composition of claim 1 , wherein the moiety is selected from the group consisting of a Tat-derived peptide, an Antennapedia carrier peptide, and a polyarginine peptide.
3. The composition of claim 1 , wherein the peptide and the moiety are linked to form a fusion peptide.
4. The composition of claim 3 , wherein the moiety is selected from the group consisting of a Tat-derived peptide, an Antennapedia carrier peptide, and a polyarginine peptide.
5. The composition of claim 3 , wherein the moiety comprises an amino acid sequence selected from the group consisting of SEQ ID NO:8 and SEQ ID NO:9.
6. The composition of claim 3 , wherein the moiety consists of an amino acid sequence selected from the group consisting of SEQ ID NO:8 and SEQ ID NO:9.
7. The composition of claim 3 , wherein the moiety comprises the amino acid sequence of SEQ ID NO:9.
8. The composition of claim 3 , wherein the moiety consists of the amino acid sequence of SEQ ID NO:9.
9. The composition of claim 1 , wherein the peptide and the moiety are linked by a Cys-Cys bond.
10. The composition of claim 9 , wherein the moiety is selected from the group consisting of a Tat-derived peptide, an Antennapedia carrier peptide, and a polyarginine peptide.
11. The composition of claim 9 , wherein the moiety comprises an amino acid sequence selected from the group consisting of SEQ ID NO:8 and SEQ ID NO:9.
12. The composition of claim 9 , wherein the moiety consists of an amino acid sequence selected from the group consisting of SEQ ID NO:8 and SEQ ID NO:9.
13. The composition of claim 9 , wherein the moiety comprises the amino acid sequence of SEQ ID NO:9.
14. The composition of claim 9 , wherein the moiety consists of the amino acid sequence of SEQ ID NO:9.
15. A conjugate comprising:
a first peptide consisting of δV1-2 (SEQ ID NO:5) and a terminal cysteine, and
a second peptide consisting of the amino acid sequence of SEQ ID NO:9,
wherein the first and second peptides are linked by a Cys-Cys bond.